medsynapse-hcp
Introduction Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, progressive β-cell dysfunction, and persistent hyperglycemia (1). Beyond glycemic dysregulation, T2DM contributes significantly to microvascular and macrovascular complications, with diabetic nephropathy (DN) being one of the most serio
Evaluating the Efficacy of Linagliptin/Empagliflozin in Type 2 Diabetes: Renal and Glycemic Outcomes

Evaluating the Efficacy of Linagliptin/Empagliflozin in Type 2 Diabetes: Renal and Glycemic Outcomes

Similar Content

Switching from Premixed Insulin to Basal Insulin with OADs
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Short-term Insulin Therapy for better Glycemic Control
Short-term Insulin Therapy for better Glycemic Control
14 Reached5 Comments6 Likes
Autoimmune Hepatitis in Girl with T1DM
Autoimmune Hepatitis in Girl with T1DM
1154 Reached2 Comments4 Likes
Risk Factors Associated Glycemia in LBW Infants
Risk Factors Associated Glycemia in LBW Infants
2793 Reached2 Comments1 Likes
Link between PCOS, Obesity and Diabetes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes